Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,997 | -92,475 | -50,882 | -118,961 | -126,222 |
| Depreciation Amortization | -2,790 | -1,553 | -898 | 4,391 | -3,652 |
| Accounts receivable | N/A | N/A | N/A | -3,045 | -841 |
| Accounts payable and accrued liabilities | 4,168 | 2,886 | 6,410 | 2,668 | -1,023 |
| Other Working Capital | -13,892 | -3,727 | -146 | -6,239 | 5,264 |
| Other Operating Activity | -3,041 | 78 | -3,537 | -54,523 | -3,048 |
| Operating Cash Flow | $-143,552 | $-94,791 | $-49,053 | $-175,709 | $-129,522 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -719 | N/A | N/A | N/A | 83,365 |
| PPE Investments | -153 | -39 | -2 | -1,468 | -1,009 |
| Net Acquisitions | N/A | N/A | N/A | 65,386 | N/A |
| Purchase Of Investment | N/A | -43,852 | -24,931 | -261,709 | N/A |
| Sale Of Investment | N/A | 137,892 | 69,319 | 340,361 | N/A |
| Other Investing Activity | -697 | -697 | -697 | 0 | 0 |
| Investing Cash Flow | $-1,569 | $93,304 | $43,689 | $142,570 | $82,356 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 143,045 | 218 | 7 | 30,118 | 30,035 |
| Common Stock Repurchased | N/A | N/A | N/A | -3,000 | -3,000 |
| Other Financing Activity | -1,150 | 0 | 0 | 15,000 | 15,000 |
| Financing Cash Flow | $141,895 | $218 | $7 | $42,118 | $42,035 |
| Exchange Rate Effect | 6 | 5 | -1 | -4 | -37 |
| Beginning Cash Position | 44,252 | 44,252 | 44,252 | 35,277 | 35,277 |
| End Cash Position | 41,032 | 42,988 | 38,894 | 44,252 | 30,109 |
| Net Cash Flow | $-3,220 | $-1,264 | $-5,358 | $8,975 | $-5,168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,552 | -94,791 | -49,053 | -175,709 | -129,522 |
| Capital Expenditure | -153 | -39 | -2 | -1,468 | -1,009 |
| Free Cash Flow | -143,705 | -94,830 | -49,055 | -177,177 | -130,531 |